Clinical-Stage Biotech Acceleration Strategies to Manage R&D Reporting, Risk and Runway

Kristen Lueck, Vice President of Operations at Auxilius
Maddie Lamberti, CPA, Manager, Customer Success at Auxilius
Adam Weisman, Chief Executive Officer and Co-Founder at Auxilius

Click to play video

Maddie Lamberti initiated her career at PwC as a financial statement auditor, specializing in the healthcare sector. Her clientele ranged from Fortune 500 pharmaceutical companies to smaller biotech firms. Subsequently, she gained significant experience in healthcare SaaS while working at Veeva and Medidata, where she assisted various life science clients in overcoming industry challenges. Presently, as the Director of Technical Accounting Success at Auxilius, Maddie plays a critical role, working closely with clients from initial implementation to achieving a stable operational state, leveraging the full potential of Auxilius software to drive excellence.

Clinical-Stage Biotech Acceleration Strategies to Manage R&D Reporting, Risk and Runway

Key strategies and considerations as clinical-stage biotech companies expand, scale and commercialize.
Common challenges in accounting for investigator spend – factoring in variation in initiation and performance across sites, asymmetrical distribution of recruitment rates and lags in data
Strategies to regain control, visibility and accuracy in forecasting pass through costs and investigator spend.
Technology enablement and automation in clinical trial accounting
Optimizing the control environment and streamlining the audit